Welcome to GDDIF 2015

GDDIF is the leading annual R&D Summit for pharma decision makers, scientific leaders and solutions experts.

GDDIF is dedicated to scientific insights, technology innovation & strategy across the entire therapeutic development lifecycle.

Evaluate, benchmark & network with over 150 fellow leaders at the 8th Annual Global Discovery to Development Innovation Forum.

What’s new this year?

  • 3 conference streams allow you to personalize your conference experience: Cherry-pick the presentations you want to hear
  • An agenda designed by R&D luminaries from pharma, biotech and academia deliver an event that is truly focused on finding answers to the key questions facing drug discovery and development
  • Tackle a variety of key issues affecting Pharma R&D
  • Representatives from the world’s biggest drug developers share a stage with their partners; Get real world evidence of partnership success
  • Over 20 case studies from big pharma – the most senior speaker line up of any R&D event
  • Over 3 hours of interactive panel sessions and roundtable discussions get right to the heart of the most pressing issues in drug discovery, development and commercialization

Key Themes in 2015:

  • Leverage Novel Technologies to Reduce Attrition and Drive Clear Decision-Making
  • Innovations in DNA & RNA Sequencing Techniques
  • Examine the Role of Predictive Biomarkers with in Depth Analysis and Real-World Case Studies
  • NGS for Cancer Drug Development & Diagnostics
  • Harness Advanced Technologies & Integrated Strategies in Data Mining and Analytics
  • The Impact of Next-Generation Sequencing on Genomics
  • Future Role of NGS in Personalised Oncology & Early Clinical Development
  • Build Successful Partnerships, Manage Alliances and Gain/Maintain a Competitive Advantage
  • Innovations in NGS for Biomarker Developmentt
  • Accelerate the Drug Discovery Process by Keeping up to speed with Key Industry Drivers and Game-Changers
  • Hone Drug Development from End-to-End: From Target Validation Through to Clinical POC studies
  • NGS Data Analysis Technologies & Platforms